$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-2.01%78.171.3%$768.79m
BIIBBiogen Inc.
-0.66%306.131.2%$594.18m
MDVNMedivation, Inc.
-0.09%80.281.5%$484.29m
AMGNAmgen Inc.
-0.27%171.511.1%$483.34m
CELGCelgene Corporation
-0.77%107.950.8%$442.28m
REGNRegeneron Pharmaceuticals, Inc.
-0.89%399.383.4%$297.68m
ILMNIllumina, Inc.
-1.04%170.424.2%$203.23m
BMRNBioMarin Pharmaceutical Inc.
-0.50%95.744.2%$177.28m
ALXNAlexion Pharmaceuticals, Inc.
-1.27%127.992.7%$169.83m
VRTXVertex Pharmaceuticals Incorporated
-0.15%96.942.2%$108.76m
INCYIncyte Corporation
0.36%81.332.5%$108.53m
IONSIonis Pharmaceuticals, Inc.
-1.88%30.3211.4%$99.14m
AAgilent Technologies, Inc.
0.66%47.630.9%$93.13m
TSROTESARO, Inc.
-0.67%85.8816.2%$86.31m
RDUSRadius Health Inc
0.46%54.5415.1%$76.49m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.